Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cpn10 dose-ranging trial in rheumatoid arthritis
ACTRN12606000041550Phase 2Completed
- Sponsor
- Cbio
- Start
- Aug 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, triple-blind trial of ala-cpn10 in rheumatoid arthritis (RA) (3 arms), sponsored by Cbio. Started Aug 2005; status: completed.
02
Drugs
ala-cpn10
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ACTRN12606000041550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000041550.